Sclerostin Modulation Holds Promise for Dental Indications

Sclerostin modulation is a novel therapeutic bone regulation strategy. The anti-sclerostin drugs, proposed in medicine for skeletal bone loss may be developed for jaw bone indications in dentistry. Alveolar bone responsible for housing dentition share common bone remodeling mechanisms with skeletal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Mohamed G., Zaher, Abbas R., Palomo, Juan Martin, Palomo, Leena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316148/
https://www.ncbi.nlm.nih.gov/pubmed/30477095
http://dx.doi.org/10.3390/healthcare6040134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316148/
https://www.ncbi.nlm.nih.gov/pubmed/30477095
http://dx.doi.org/10.3390/healthcare6040134

Ejemplares similares